Leonard Frank X - Nov 1, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
President, CNS Cancers US
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Stock symbol
NVCR
Transactions as of
Nov 1, 2022
Transactions value $
$849,779
Form type
4
Date filed
11/3/2022, 04:42 PM
Previous filing
Oct 17, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $0 +6.83K +15.66% $0.00 50.5K Nov 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $850K +11.6K $73.20 11.6K Nov 1, 2022 Ordinary Shares 11.6K $73.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units that are scheduled to vest in equal installments on each of November 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F2 Options to buy 11,609 ordinary shares will vest and become exercisable in equal installments on each of November 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.